Determining cell-of-origin subtypes of diffuse large B-cell lymphoma using gene expression in formalin-fixed paraffin-embedded tissue

David W. Scott, George W. Wright, P. Mickey Williams, Chih Jian Lih, William Walsh, Elaine S. Jaffe, Andreas Rosenwald, Elias Campo, Wing C. Chan, Joseph M. Connors, Erlend B. Smeland, Anja Mottok, Rita M. Braziel, German Ott, Jan Delabie, Raymond R. Tubbs, James R. Cook, Dennis D. Weisenburger, Timothy Charles Greiner, Betty J. Glinsmann-Gibson & 4 others Kai Fu, Louis M. Staudt, Randy D. Gascoyne, Lisa M. Rimsza

Research output: Contribution to journalArticle

232 Citations (Scopus)

Abstract

The assignment of diffuse large B-cell lymphoma into cell-of-origin (COO) groups is becoming increasingly important with the emergence of novel therapies that have selective biological activity in germinal center B cell-like or activated B cell-like groups. The Lymphoma/Leukemia Molecular Profiling Project's Lymph2Cx assay is a parsimonious digital gene expression (NanoString)-based test for COO assignment in formalin-fixed paraffin-embedded tissue (FFPET). The 20-gene assay was trained using 51 FFPET biopsies; the locked assay was then validated using an independent cohort of 68 FFPET biopsies. Comparisons were made with COO assignment using the original COO model on matched frozen tissue. In the validation cohort, the assay was accurate, with only 1 case with definitive COO being incorrectly assigned, and robust, with >95% concordance of COO assignment between 2 independent laboratories. These qualities, along with the rapid turnaround time,make Lymph2Cx attractive for implementation in clinical trials and, ultimately, patient management.

Original languageEnglish (US)
Pages (from-to)1214-1217
Number of pages4
JournalBlood
Volume123
Issue number8
DOIs
StatePublished - Feb 20 2014

Fingerprint

Lymphoma, Large B-Cell, Diffuse
Gene expression
Paraffin
Formaldehyde
Assays
Cells
Tissue
Gene Expression
Biopsy
Turnaround time
B-Lymphocytes
Bioactivity
Germinal Center
Genes
Lymphoma
Leukemia
Clinical Trials

ASJC Scopus subject areas

  • Biochemistry
  • Immunology
  • Hematology
  • Cell Biology

Cite this

Scott, D. W., Wright, G. W., Williams, P. M., Lih, C. J., Walsh, W., Jaffe, E. S., ... Rimsza, L. M. (2014). Determining cell-of-origin subtypes of diffuse large B-cell lymphoma using gene expression in formalin-fixed paraffin-embedded tissue. Blood, 123(8), 1214-1217. https://doi.org/10.1182/blood-2013-11-536433

Determining cell-of-origin subtypes of diffuse large B-cell lymphoma using gene expression in formalin-fixed paraffin-embedded tissue. / Scott, David W.; Wright, George W.; Williams, P. Mickey; Lih, Chih Jian; Walsh, William; Jaffe, Elaine S.; Rosenwald, Andreas; Campo, Elias; Chan, Wing C.; Connors, Joseph M.; Smeland, Erlend B.; Mottok, Anja; Braziel, Rita M.; Ott, German; Delabie, Jan; Tubbs, Raymond R.; Cook, James R.; Weisenburger, Dennis D.; Greiner, Timothy Charles; Glinsmann-Gibson, Betty J.; Fu, Kai; Staudt, Louis M.; Gascoyne, Randy D.; Rimsza, Lisa M.

In: Blood, Vol. 123, No. 8, 20.02.2014, p. 1214-1217.

Research output: Contribution to journalArticle

Scott, DW, Wright, GW, Williams, PM, Lih, CJ, Walsh, W, Jaffe, ES, Rosenwald, A, Campo, E, Chan, WC, Connors, JM, Smeland, EB, Mottok, A, Braziel, RM, Ott, G, Delabie, J, Tubbs, RR, Cook, JR, Weisenburger, DD, Greiner, TC, Glinsmann-Gibson, BJ, Fu, K, Staudt, LM, Gascoyne, RD & Rimsza, LM 2014, 'Determining cell-of-origin subtypes of diffuse large B-cell lymphoma using gene expression in formalin-fixed paraffin-embedded tissue', Blood, vol. 123, no. 8, pp. 1214-1217. https://doi.org/10.1182/blood-2013-11-536433
Scott, David W. ; Wright, George W. ; Williams, P. Mickey ; Lih, Chih Jian ; Walsh, William ; Jaffe, Elaine S. ; Rosenwald, Andreas ; Campo, Elias ; Chan, Wing C. ; Connors, Joseph M. ; Smeland, Erlend B. ; Mottok, Anja ; Braziel, Rita M. ; Ott, German ; Delabie, Jan ; Tubbs, Raymond R. ; Cook, James R. ; Weisenburger, Dennis D. ; Greiner, Timothy Charles ; Glinsmann-Gibson, Betty J. ; Fu, Kai ; Staudt, Louis M. ; Gascoyne, Randy D. ; Rimsza, Lisa M. / Determining cell-of-origin subtypes of diffuse large B-cell lymphoma using gene expression in formalin-fixed paraffin-embedded tissue. In: Blood. 2014 ; Vol. 123, No. 8. pp. 1214-1217.
@article{425c5398aacb4d9dae60bb36a166f822,
title = "Determining cell-of-origin subtypes of diffuse large B-cell lymphoma using gene expression in formalin-fixed paraffin-embedded tissue",
abstract = "The assignment of diffuse large B-cell lymphoma into cell-of-origin (COO) groups is becoming increasingly important with the emergence of novel therapies that have selective biological activity in germinal center B cell-like or activated B cell-like groups. The Lymphoma/Leukemia Molecular Profiling Project's Lymph2Cx assay is a parsimonious digital gene expression (NanoString)-based test for COO assignment in formalin-fixed paraffin-embedded tissue (FFPET). The 20-gene assay was trained using 51 FFPET biopsies; the locked assay was then validated using an independent cohort of 68 FFPET biopsies. Comparisons were made with COO assignment using the original COO model on matched frozen tissue. In the validation cohort, the assay was accurate, with only 1 case with definitive COO being incorrectly assigned, and robust, with >95{\%} concordance of COO assignment between 2 independent laboratories. These qualities, along with the rapid turnaround time,make Lymph2Cx attractive for implementation in clinical trials and, ultimately, patient management.",
author = "Scott, {David W.} and Wright, {George W.} and Williams, {P. Mickey} and Lih, {Chih Jian} and William Walsh and Jaffe, {Elaine S.} and Andreas Rosenwald and Elias Campo and Chan, {Wing C.} and Connors, {Joseph M.} and Smeland, {Erlend B.} and Anja Mottok and Braziel, {Rita M.} and German Ott and Jan Delabie and Tubbs, {Raymond R.} and Cook, {James R.} and Weisenburger, {Dennis D.} and Greiner, {Timothy Charles} and Glinsmann-Gibson, {Betty J.} and Kai Fu and Staudt, {Louis M.} and Gascoyne, {Randy D.} and Rimsza, {Lisa M.}",
year = "2014",
month = "2",
day = "20",
doi = "10.1182/blood-2013-11-536433",
language = "English (US)",
volume = "123",
pages = "1214--1217",
journal = "Blood",
issn = "0006-4971",
publisher = "American Society of Hematology",
number = "8",

}

TY - JOUR

T1 - Determining cell-of-origin subtypes of diffuse large B-cell lymphoma using gene expression in formalin-fixed paraffin-embedded tissue

AU - Scott, David W.

AU - Wright, George W.

AU - Williams, P. Mickey

AU - Lih, Chih Jian

AU - Walsh, William

AU - Jaffe, Elaine S.

AU - Rosenwald, Andreas

AU - Campo, Elias

AU - Chan, Wing C.

AU - Connors, Joseph M.

AU - Smeland, Erlend B.

AU - Mottok, Anja

AU - Braziel, Rita M.

AU - Ott, German

AU - Delabie, Jan

AU - Tubbs, Raymond R.

AU - Cook, James R.

AU - Weisenburger, Dennis D.

AU - Greiner, Timothy Charles

AU - Glinsmann-Gibson, Betty J.

AU - Fu, Kai

AU - Staudt, Louis M.

AU - Gascoyne, Randy D.

AU - Rimsza, Lisa M.

PY - 2014/2/20

Y1 - 2014/2/20

N2 - The assignment of diffuse large B-cell lymphoma into cell-of-origin (COO) groups is becoming increasingly important with the emergence of novel therapies that have selective biological activity in germinal center B cell-like or activated B cell-like groups. The Lymphoma/Leukemia Molecular Profiling Project's Lymph2Cx assay is a parsimonious digital gene expression (NanoString)-based test for COO assignment in formalin-fixed paraffin-embedded tissue (FFPET). The 20-gene assay was trained using 51 FFPET biopsies; the locked assay was then validated using an independent cohort of 68 FFPET biopsies. Comparisons were made with COO assignment using the original COO model on matched frozen tissue. In the validation cohort, the assay was accurate, with only 1 case with definitive COO being incorrectly assigned, and robust, with >95% concordance of COO assignment between 2 independent laboratories. These qualities, along with the rapid turnaround time,make Lymph2Cx attractive for implementation in clinical trials and, ultimately, patient management.

AB - The assignment of diffuse large B-cell lymphoma into cell-of-origin (COO) groups is becoming increasingly important with the emergence of novel therapies that have selective biological activity in germinal center B cell-like or activated B cell-like groups. The Lymphoma/Leukemia Molecular Profiling Project's Lymph2Cx assay is a parsimonious digital gene expression (NanoString)-based test for COO assignment in formalin-fixed paraffin-embedded tissue (FFPET). The 20-gene assay was trained using 51 FFPET biopsies; the locked assay was then validated using an independent cohort of 68 FFPET biopsies. Comparisons were made with COO assignment using the original COO model on matched frozen tissue. In the validation cohort, the assay was accurate, with only 1 case with definitive COO being incorrectly assigned, and robust, with >95% concordance of COO assignment between 2 independent laboratories. These qualities, along with the rapid turnaround time,make Lymph2Cx attractive for implementation in clinical trials and, ultimately, patient management.

UR - http://www.scopus.com/inward/record.url?scp=84899136028&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84899136028&partnerID=8YFLogxK

U2 - 10.1182/blood-2013-11-536433

DO - 10.1182/blood-2013-11-536433

M3 - Article

VL - 123

SP - 1214

EP - 1217

JO - Blood

JF - Blood

SN - 0006-4971

IS - 8

ER -